Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex
- PMID: 11729018
- DOI: 10.1176/appi.ajp.158.12.2015
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex
Abstract
Objective: The role of dopamine in the addictive process (loss of control and compulsive drug intake) is poorly understood. A consistent finding in drug-addicted subjects is a lower level of dopamine D2 receptors. In cocaine abusers, low levels of D2 receptors are associated with a lower level of metabolism in the orbitofrontal cortex. Because the orbitofrontal cortex is associated with compulsive behaviors, its disruption may contribute to compulsive drug intake in addicted subjects. This study explored whether a similar association occurs in methamphetamine abusers.
Method: Fifteen methamphetamine abusers and 20 non-drug-abusing comparison subjects were studied with positron emission tomography (PET) and [11C]raclopride to assess the availability of dopamine D2 receptors and with [18F]fluorodeoxyglucose to assess regional brain glucose metabolism, a marker of brain function.
Results: Methamphetamine abusers had a significantly lower level of D2 receptor availability than comparison subjects (a difference of 16% in the caudate and 10% in the putamen). D2 receptor availability was associated with metabolic rate in the orbitofrontal cortex in abusers and in comparison subjects.
Conclusions: Lower levels of dopamine D2 receptor availability have been previously reported in cocaine abusers, alcoholics, and heroine abusers. This study extends this finding to methamphetamine abusers. The association between level of dopamine D2 receptors and metabolism in the orbitofrontal cortex in methamphetamine abusers, which replicates previous findings in cocaine abusers, suggests that D2 receptor-mediated dysregulation of the orbitofrontal cortex could underlie a common mechanism for loss of control and compulsive drug intake in drug-addicted subjects.
Similar articles
-
Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.Am J Psychiatry. 1999 Jan;156(1):19-26. doi: 10.1176/ajp.156.1.19. Am J Psychiatry. 1999. PMID: 9892293
-
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.Arch Gen Psychiatry. 2004 Jan;61(1):73-84. doi: 10.1001/archpsyc.61.1.73. Arch Gen Psychiatry. 2004. PMID: 14706946
-
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.Synapse. 1993 Jun;14(2):169-77. doi: 10.1002/syn.890140210. Synapse. 1993. PMID: 8101394
-
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex.Cereb Cortex. 2000 Mar;10(3):318-25. doi: 10.1093/cercor/10.3.318. Cereb Cortex. 2000. PMID: 10731226 Review.
-
Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.J Addict Dis. 2004;23(3):39-53. doi: 10.1300/J069v23n03_04. J Addict Dis. 2004. PMID: 15256343 Review.
Cited by
-
Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis.PLoS One. 2015 Feb 11;10(2):e0116961. doi: 10.1371/journal.pone.0116961. eCollection 2015. PLoS One. 2015. PMID: 25671639 Free PMC article.
-
The contribution of brain reward circuits to the obesity epidemic.Neurosci Biobehav Rev. 2013 Nov;37(9 Pt A):2047-58. doi: 10.1016/j.neubiorev.2012.12.001. Epub 2012 Dec 10. Neurosci Biobehav Rev. 2013. PMID: 23237885 Free PMC article. Review.
-
HIV Subtypes B and C gp120 and Methamphetamine Interaction: Dopaminergic System Implicates Differential Neuronal Toxicity.Sci Rep. 2015 Jun 9;5:11130. doi: 10.1038/srep11130. Sci Rep. 2015. PMID: 26057350 Free PMC article.
-
Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.Int J Environ Res Public Health. 2011 Dec;8(12):4425-59. doi: 10.3390/ijerph8124425. Epub 2011 Nov 29. Int J Environ Res Public Health. 2011. PMID: 22408582 Free PMC article.
-
Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?Neurosci Biobehav Rev. 2013 Mar;37(3):300-16. doi: 10.1016/j.neubiorev.2012.12.003. Epub 2012 Dec 17. Neurosci Biobehav Rev. 2013. PMID: 23253945 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical